Compare PTCT & APLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTCT | APLD |
|---|---|---|
| Founded | 1998 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 5.1B |
| IPO Year | 2006 | 2021 |
| Metric | PTCT | APLD |
|---|---|---|
| Price | $56.37 | $11.48 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 16 |
| Target Price | ★ $100.47 | $59.94 |
| AVG Volume (30 Days) | 939.5K | ★ 21.9M |
| Earning Date | 10-29-2026 | 01-06-2027 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 264.48 | 21.55 |
| EPS | ★ 0.34 | N/A |
| Revenue | $264,734,000.00 | ★ $611,311,000.00 |
| Revenue This Year | N/A | $59.91 |
| Revenue Next Year | $8.29 | $101.09 |
| P/E Ratio | $171.44 | ★ N/A |
| Revenue Growth | 36.19 | ★ 167.45 |
| 52 Week Low | $58.15 | $13.12 |
| 52 Week High | $90.87 | $50.73 |
| Indicator | PTCT | APLD |
|---|---|---|
| Relative Strength Index (RSI) | 33.38 | 29.02 |
| Support Level | N/A | N/A |
| Resistance Level | $69.74 | $29.08 |
| Average True Range (ATR) | 2.50 | 1.57 |
| MACD | -0.78 | -0.19 |
| Stochastic Oscillator | 1.01 | 1.04 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Applied Digital Corp is a U.S. based designer, developer, owner, and operator of large-scale, purpose-built data centers engineered to support high-performance computing (HPC) workloads, including artificial intelligence (AI), machine learning, and other accelerated-compute applications. It design, build, and operate high-performance, sustainably engineered data centers which it refer to as AI factories and deliver that capacity to investment-grade hyper scalers and other compute customers under long-term lease and hosting arrangements. The company has two segments Data Center Hosting Business, and HPC Hosting Business. The company generates majority of revenue from Data Center Hosting Business segment. Its solutions are Digital Infrastructure, and AI Factories.